Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
RenViva is a physician-owned and led outpatient dialysis service provider founded in 2016. The company operates 16 free-standing facilities across eight U.S. states, offering both traditional in-center hemodialysis and home-based therapies. It has achieved some of the highest home dialysis adoption rates in the industry—already meeting CMS’s goal of 50% home treatment by 2025—and is recognized for superior patient outcomes and operational efficiency. Their model emphasizes patient education, staff training via proprietary platforms, and strong partnerships with nephrologists to drive innovation in care delivery.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on RenViva.